American International Group’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-32,430
Closed -$1.42M 1272
2024
Q1
$1.42M Buy
32,430
+2,514
+8% +$108K 0.01% 1129
2023
Q4
$1.06M Buy
29,916
+2,819
+10% +$84.1K ﹤0.01% 1266
2023
Q3
$731K Buy
27,097
+964
+4% +$24.4K ﹤0.01% 1393
2023
Q2
$614K Buy
26,133
+4,756
+22% +$97.8K ﹤0.01% 1518
2023
Q1
$294K Buy
21,377
+426
+2% +$7.1K ﹤0.01% 1897
2022
Q4
$381K Buy
20,951
+4,067
+24% +$68.4K ﹤0.01% 1754
2022
Q3
$252K Buy
16,884
+238
+1% +$3.09K ﹤0.01% 2028
2022
Q2
$230K Buy
16,646
+383
+2% +$4.26K ﹤0.01% 2099
2022
Q1
$182K Sell
16,263
-1,145
-7% -$16.9K ﹤0.01% 2294
2021
Q4
$412K Sell
17,408
-521
-3% -$12.1K ﹤0.01% 1939
2021
Q3
$457K Buy
17,929
+2,201
+14% +$51.4K ﹤0.01% 1909
2021
Q2
$330 Buy
15,728
+5,440
+53% +$112K ﹤0.01% 2194
2021
Q1
$242 Buy
10,288
+1,031
+11% +$19.9K ﹤0.01% 2269
2020
Q4
$130 Sell
9,257
-265
-3% -$3.59K ﹤0.01% 2520
2020
Q3
$120K Buy
9,522
+2,167
+29% +$26.8K ﹤0.01% 2428
2020
Q2
$105K Buy
+7,355
New +$57.9K ﹤0.01% 2505

Other funds holding IDYA

American International Group's IDYA Position: Q2 2024 in Review

American International Group sold out of IDEAYA Biosciences (IDYA) in Q2 2024, closing a stake of 32,430 shares — an estimated $1.42M sold.

American International Group first reported a position in IDYA in Q2 2020 and held it in 16 quarters. The position peaked at $1.42M in Q1 2024. 199 funds tracked by Wall St. Rank hold IDYA as of Q2 2024.

  • American International Group reported no remaining IDEAYA Biosciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 32,430 IDEAYA Biosciences shares in Q2 2024, an estimated $1.42M.
  • American International Group first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 16 quarters.
  • American International Group's IDEAYA Biosciences position peaked at $1.42M in Q1 2024.
  • 199 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.